Keith Michael Gottesdiener, CEO & President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 17,070 shares at $30.06 ($513K) on 2019-03-13, disclosed to the SEC on 2019-03-15.
Open-market sale of $513k RYTM by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.06 | 7,782 | $234K | 45.6% |
| 2 | $30.06 | 7,782 | $234K | 45.6% |
| 3 | $30.05 | 1,506 | $45K | 8.8% |
| Total | $30.06 avg | 17,070 | $513K | 100% |
| Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |
| RYTM | SELL | 2019-01-24 | $945K | — | Filing → |